- Home
- TRAK vs FENC Comparison
TRAK vs FENC Comparison
Compare TRAK & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAK
- FENC
- Stock Information
- Founded
- TRAK 1990
- FENC 1996
- Country
- TRAK United States
- FENC United States
- Employees
- TRAK N/A
- FENC N/A
- Industry
- TRAK EDP Services
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRAK Technology
- FENC Health Care
- Exchange
- TRAK Nasdaq
- FENC Nasdaq
- Market Cap
- TRAK 274.4M
- FENC 234.9M
- IPO Year
- TRAK 1998
- FENC 2001
- Fundamental
- Price
- TRAK $13.73
- FENC $7.87
- Analyst Decision
- TRAK
- FENC Strong Buy
- Analyst Count
- TRAK 0
- FENC 2
- Target Price
- TRAK N/A
- FENC $13.50
- AVG Volume (30 Days)
- TRAK 58.0K
- FENC 159.3K
- Earning Date
- TRAK 11-13-2025
- FENC 11-13-2025
- Dividend Yield
- TRAK 0.60%
- FENC N/A
- EPS Growth
- TRAK 19.98
- FENC N/A
- EPS
- TRAK 0.36
- FENC N/A
- Revenue
- TRAK $23,136,391.00
- FENC $38,790,000.00
- Revenue This Year
- TRAK $12.20
- FENC N/A
- Revenue Next Year
- TRAK $20.00
- FENC $64.79
- P/E Ratio
- TRAK $38.06
- FENC N/A
- Revenue Growth
- TRAK 11.05
- FENC N/A
- 52 Week Low
- TRAK $13.04
- FENC $4.60
- 52 Week High
- TRAK $25.01
- FENC $9.92
- Technical
- Relative Strength Index (RSI)
- TRAK 33.62
- FENC 42.10
- Support Level
- TRAK $14.17
- FENC $7.53
- Resistance Level
- TRAK $15.42
- FENC $9.00
- Average True Range (ATR)
- TRAK 0.58
- FENC 0.55
- MACD
- TRAK -0.14
- FENC 0.01
- Stochastic Oscillator
- TRAK 26.68
- FENC 17.69
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.